The tumor suppressor protein menin inhibits AKT activation by regulating its cellular localization

Cancer Research

Volumn 71, Issue 2, 2011, Pages 371-382

  Wang, Yan ^a   Ozawa, Atsushi ^a,b   Zaman, Shadia ^a   Prasad, Nijaguna B ^c,d   Chandrasekharappa, Settara C ^c   Agarwal, Sunita K ^a   Marx, Stephen J ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DIMETHYL SULFOXIDE; GROWTH FACTOR; METHIONINE; PROTEIN KINASE B; TUMOR SUPPRESSOR PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INHIBITION; CELL MEMBRANE; CELLULAR DISTRIBUTION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ENZYME ACTIVITY; MOUSE; MULTIPLE ENDOCRINE NEOPLASIA; NONHUMAN; ONCOGENE; PANCREAS ADENOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; TUMOR GROWTH;

ADENOMA, ISLET CELL; ANIMALS; CELL GROWTH PROCESSES; CELL MEMBRANE; ENZYME ACTIVATION; HEK293 CELLS; HUMANS; MICE; MICROSCOPY, CONFOCAL; PANCREATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; TRANSFECTION;

EID: 78751554804     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-10-3221     Document Type: Article

References (28)

1. Gagel RF, Marx SJ. Multiple endocrine neoplasia. In: Kronenberg HM, Melmed S, Polonsky KS, Largen PR, editors. Williams Textbook of Endocrinology. 11th ed. Philadelphia, PA: W.B. Saunders Company; 2007. p. 1705-46.
2. Chandrasekharappa SC, Guru SC, Manickam P, Olufemi SE, Collins FS, Emmert-Buck MR, et al. Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science 1997;276:404-7.
3. Lemos MC, Thakker RV. Multiple endocrine neoplasia type 1 (MEN1): analysis of 1336 mutations reported in the first decade following identification of the gene. Hum Mutat 2008;29:22-32.
4. La P, Desmond A, Hou Z, Silva AC, Schnepp RW, Hua X. Tumor suppressor menin: the essential role of nuclear localization signal domainsincoordinatinggeneexpression.Oncogene2006;25:3537-46.
5. Cao Y, Liu R, Jiang X, Lu J, Jiang J, Zhang C, et al. Nuclearcytoplasmic shuttling of menin regulates nuclear translocation of {beta}-catenin. Mol Cell Biol 2009;29:5477-87.
6. Yang Y, Hua X. In search of tumor suppressing functions of menin. Mol Cell Endocrinol 2007;265-266:34-41.
7. Vivanco I, Sawyers CL. The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat Rev Cancer 2002;2:489-501.
8. Elghazi L, Balcazar N, Bernal-Mizrachi E. Emerging role of protein kinase B/Akt signaling in pancreatic beta-cell mass and function. Int J Biochem Cell Biol 2006;38:157-63.
9. Musat M, Korbonits M, Kola B, Borboli N, Hanson MR, Nanzer A M, et al. Enhanced protein kinase B/Akt signalling in pituitary tumours. Endocr Relat Cancer 2005;12:423-33.
10. Bernal-Mizrachi E, Wen W, Stahlhut S, Welling CM, Permutt MA. Islet beta cell expression of constitutively active Akt1/PKB alpha induces striking hypertrophy, hyperplasia, and hyperinsulinemia. J Clin Invest 2001;108:1631-8.
11. Tuttle RL, Gill NS, Pugh W, Lee JP, Koeberlein B, Furth EE, et al. Regulation of pancreatic beta-cell growth and survival by the serine/ threonine protein kinase Akt1/PKBalpha. Nat Med 2001;7:1133-7.
12. Segouffin-Cariou C, Billaud M. Transforming ability of MEN2A-RET requires activation of the phosphatidylinositol 3-kinase/AKT signaling pathway. J Biol Chem 2000;275:3568-76.
13. Guru SC, Goldsmith PK, Burns AL, Marx SJ, Spiegel AM, Collins FS, et al. Menin, the product of the MEN1 gene, is a nuclear protein. Proc Natl Acad Sci U S A 1998;95:1630-4.
14. Agarwal SK, Novotny EA, Crabtree JS, Weitzman B, Yaniv M, Burns AL, et al. Transcription factor JunD, deprived of menin, switches from growth suppressor to growth promoter. Proc Natl Acad Sci U S A 2003;100:10770-5.
15. Crabtree JS, Scacheri PC, Ward JM, Garrett-Beal L, Emmert-Buck MR, Edgemon KA, et al. A mouse model of multiple endocrine neoplasia, type 1, develops multiple endocrine tumors. Proc Natl Acad Sci U S A 2001;98:1118-23.
16. He TC, Zhou S, da Costa LT, Yu J, Kinzler KW, Vogelstein B. A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci U S A 1998;95:2509-14.
17. Heppner C, Bilimoria KY, Agarwal SK, Kester M, Whitty LJ, Guru SC, et al. The tumor suppressor protein menin interacts with NFkappaB proteins and inhibits NF-kappaB-mediated transactivation. Oncogene 2001;20:4917-25.
18. Sukhodolets KE, Hickman AB, Agarwal SK, Sukhodolets MV, Obungu V H, Novotny EA, et al. The 32-kilodalton subunit of replication protein A interacts with menin, the product of the MEN1 tumor suppressor gene. Mol Cell Biol 2003;23:493-509.
19. Wang Y, Culty M. Identification and distribution of a novel plateletderived growth factor receptor beta variant: effect of retinoic acid and involvement in cell differentiation. Endocrinology 2007;148: 2233-50.
20. Wang Y, Thuillier R, Culty M. Prenatal estrogen exposure differentially affects estrogen receptor-associated proteins in rat testis gonocytes. Biol Reprod 2004;71:1652-64.
21. Schnepp RW, Mao H, Sykes SM, Zong WX, Silva A, La P, et al. Menin induces apoptosis in murine embryonic fibroblasts. J Biol Chem 2004;279:10685-91.
22. Banck MS, Beaven SW, Narla G, Walsh MJ, Friedman SL, Beutler AS. KLF6 degradation after apoptotic DNA damage. FEBS Lett 2006; 580:6981-6.
23. Muller D, Jones PM, Persaud SJ. Autocrine anti-apoptotic and proliferative effects of insulin in pancreatic beta-cells. FEBS Lett 2006;580:6977-80.
24. Huang SC, Zhuang Z, Weil RJ, Pack S, Wang C, Krutzsch HC, et al. Nuclear/cytoplasmic localization of the multiple endocrine neoplasia type 1 gene product, menin. Lab Invest 1999;79: 301-10.
25. Wautot V, Khodaei S, Frappart L, Buisson N, Baro E, Lenoir GM, et al. Expression analysis of endogenous menin, the product of the multiple endocrine neoplasia type 1 gene, in cell lines and human tissues. Int J Cancer 2000;85:877-81.
26. Lopez-Egido J, Cunningham J, Berg M, Oberg K, Bongcam- Rudloff E, Gobl A. Menin's interaction with glial fibrillary acidic protein and vimentin suggests a role for the intermediate filament network in regulating menin activity. Exp Cell Res 2002; 278:175-83.
27. Maehama T, Dixon JE. The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5- trisphosphate. J Biol Chem 1998;273:13375-8.
28. Marx SJ. Molecular genetics of multiple endocrine neoplasia types 1 and 2. Nat Rev Cancer 2005;5:367-75.